Eden Research e Eastman assinam acordo de comercialização para produto nematicida
Eden Research plc, has signed an exclusive commercialization agreement with Taminco BVBA, a subsidiary of Eastman Chemical Co.’s global crop protection division (Eastman), following a series of successful field trials and market evaluations conducted by Eastman from 2014 through 2016.
The agreement grants Eastman the exclusive right to develop the market for Eden’s nematicide formulation, which will be marketed by Eastman as Cedroz. Eastman will pay Eden, a natural bio-control products and microencapsulation technologies manufacturer, an upfront fee, as well as annual milestone payments until 2019 when it is expected that sales will commence. Eastman will take on the responsibility for the registration of Cedroz in each territory while Eden retains responsibility for the registration of the active ingredients and will supply Eastman with its product requirements globally. The agreement covers 29 countries including the largest markets for nematicide products globally.
Nematodes are a major category of plant pest that cause an estimated $300 million of damage per year in Europe alone. Most major crops are affected by nematodes with particular damage being done in the high value fruit and vegetables segment. This segment of the nematicide market is in the region of $550 million globally. Given the withdrawal and restriction in use of a number of key products that were well established in the market, Eden and Eastman are optimistic that Cedroz will become an effective tool for growers whose options are becoming limited when facing the issue of nematode control.
Aside from its efficacy, Cedroz benefits from the fact that its active ingredients are exempt from Maximum Residue Level (MRL) limits in the European Union. This translates into a clear benefit for growers when considering treatment programs, as Cedroz can be used without regard to concern for residues, thus allowing growers to protect their crops right up to the point of harvest.